Clinical Trial Update: A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a hypoxia-inducible CAR-T cell therapy targeting AXL and CD73 for advanced gastric cancer; the study status is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• AXL-CD73 hypoxia-inducible CAR-T cell therapy

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Stage IV Gastric Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING